Cancer associated with AIDS

Share This Post

Acquired Immunodeficiency Syndrome (AIDS) is a potentially life threatening condition caused by the Human Immunodeficiency Virus (HIV) and is transmitted from human to human as a sexually transmitted disease, through contact with infected blood, and from mother to child during pregnancy, childbirth, and breast feeding . HIV damages the immune system of the human body, and thus we have less ability or inability to fight any infection or disease. As of date, there is no cure for HIV / AIDS but we have surely been able to halt the progression of the disease with effective medicines.

As we all know, our innate immunity plays a major role in the initiation and progression of cancer in the human body, so it does not come as a surprise that HIV / AIDS comes with an increased susceptibility to different types and forms of cancer. AIDS-related cancer refers to any cancer that is more likely to occur in a person who is infected with HIV. The list includes, but is not limited to, Kaposi’s sarcoma (KS), lymphoma, including Non- Hodgkin’s Lymphoma (NHL) and Hodgkin’s Lymphoma (HL / HD), Cervical cancer and cancers of the mouth, throat, liver, lung, and anus. This list can be further extended to angiosarcoma, penile cancer, testicular cancer, colorectal cancer, and different varieties of skin cancer, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. Of these, a trio of cancers, namely, KS, NHL, and cervical cancer, are referred to as AIDS-defining cancers, meaning that the development of any of these cancers in an HIV positive patient signifies the progression of HIV positivity to full blown AIDS. This trio of cancers is described below

  1. Kaposi’s Sarcoma: Kaposi’s sarcoma is a soft tissue sarcoma (sarcoma = cancer arising from the connective tissue of the body), which can be divided into endemic KS and epidemic KS. Endemic KS is unrelated to HIV / AIDS and has been traditionally associated with young African males, those of Jewish or Mediterranean descent, or persons who are on immunosuppressive therapy following an organ transplantation. Epidemic KS is associated with HIV / AIDS and typically, homosexual men with HIV / AIDS associated with Human Herpesvirus (HHV) type 8 infection.
  2. Non – Hodgkin’s lymphoma: The lymphatic system is a network of lymph vessels and lymph nodes in the human body that carries a colourless ultrafiltrate of the blood called lymph, which typically contains lymphocytes, a type of white blood cell. The lymphatic system has an important role to play in the defence mechanisms of our body. Apart from the lymphatic channels and the lymph nodes, the spleen (filters blood and makes lymphocytes), the thymus, the tonsils, and the bone marrow also form part of the lymphatic system. NHL is a type of cancer of the lymphatic system where the healthy cells of the lymphatic system multiply rapidly, grow out of control, and may or may not form a tumour. Although there are many different types of NHL, the ones that are most commonly associated with HIV / AIDS are aggressive B cell lymphomas, especially diffuse large B cell lymphoma (DLBCL) and Burkitt’s lymphoma; primary central nervous system lymphoma (primary CNS lymphoma) affecting the brain; and primary effusion lymphoma, which causes fluid accumulation around the lungs (pleural effusion), heart (pericardial effusion), and abdominal cavity (ascites).
  3. Cervical cancer / cancer of the uterine cervix: The uterine cervix, commonly known as the cervix, is the lowermost part of the uterus, which projects out into the vaginal cavity and thus forms the birth canal. Women with HIV / AIDS have a higher propensity to develop a precancerous condition of the cervix known as cervical intraepithelial neoplasia (CIN). There are different grades of CIN and its association with the Human Papilloma Virus (HPV); mainly types 16 and 18, has been proved conclusively. A high grade CIN (CIN – III) can progress to invasive cervical cancer. Typically, it takes decades for a CIN to progress to invasive cervical cancer, but a co-infection with HIV / AIDS can hasten the process of development and progression to invasive cancer by a mere few years.

The management and treatment of AIDS – related cancers is no different from accepted treatment protocols for these cancers without the association of HIV / AIDS but we have to additionally treat the HIV / AIDS simultaneously and be extra vigilant about the additional immunosuppression due to the cancer, the disease (HIV / AIDS) and that induced by the treatment.

written by Dr. Partha Mukhopadhyay

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy